Changyi Wins Industrial Excellence Award in Weixin Pay Application Competition
iClick Interactive Asia Group Limited (“iClick” or the “Company”), an independent online marketing and enterprise data solutions provider in China, announced that Changyi (Shanghai) Information Technology Co., Ltd (“Changyi”), a subsidiary of iClick, has been awarded a major industry accolade by Tencent’s Weixin Pay for its outstanding solution that helps optimize traffic management of client brands’ mini-programs and boost sales through the Weixin Pay platform. Changyi’s solution received praise from the panel for its innovativeness and the improvement it brings to both consumer experience and loyalty. The Weixin Pay Application Competition is a competition initiated by Weixin Pay that aims to locate creative partners within the WeChat ecosystem with the goal of seeking innovation and upgrading different industries.
Marketing Technology News: Viant Analysis Provides Insights into TV’s Role in an Omnichannel, COVID-19 World
“We are delighted to see iClick’s subsidiary Changyi receive recognition from our long-term strategic partner Tencent,” said Jian “T.J.” Tang, Chief Executive Officer and Co-Founder of iClick. “This latest accolade is further evidence of the impact our Enterprise Solutions businesses have made in helping retail brands obtain a greater market share by the application of creative products and our advanced data operation capabilities. In the challenging context of the COVID-19 outbreak we have seen increased demand for our Enterprise Solutions, and going forward we expect to expand this business, by further innovation in our product offerings and optimization of our services, as we continue to unlock the huge potential of smart retail for our clients.”
Marketing Technology News: Yext Declares War on Wrong Answers with New Integrated Marketing Campaign
Earlier this year OptAim (Beijing) Information Technology Co., Ltd, another subsidiary of iClick, was recognized as 2019 Gold Service Provider and won three major annual awards from Tencent Ads for the second half of 2019, including “Outstanding Contribution of the Year”, “Best Technology & Data Application Award” and “Best Branding Award”.
Related Posts
Seizing Entrepreneurial Opportunities in Pudong: Embracing the Rise of Returnee Entrepreneurs
From November 9th to 11th, under the guidance of the United Front Work Department of the Shanghai Municipal Committee (Overseas Chinese Affairs Office of the Municipal Government), the “Overseas Chinese Innovation and Entrepreneurship Study Camp” (the 3rd Study Camp for Overseas Chinese Young Science and Technology Entrepreneurs and the 16th Study C
NGS test completed in one day, lung and colon cancer test kits receive FDA approval
NGS (next generation sequencing technology), also known as high-throughput sequencing technology. It is commonly used for genetic disease screening, prenatal testing or diagnosis, oncology clinical diagnosis, pharmacogenomic testing, cancer chemotherapy and treatment, and single gene disease screening or diagnosis. It is capable of sequencing hundreds of thousa
Cancer Dx Firm Pillar Biosciences Gets $18M Investment From ORI Healthcare
NEW YORK (GenomeWeb) – Hong Kong-based venture capital group ORI Healthcare Fund announced today that it has made an $18 million investment in Boston-based cancer molecular diagnostics startup Pillar Biosciences. According to ORI, Pillar is advancing a patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which offer
Laekna HK$791 million IPO
We advised Laekna on its IPO and HKEX listing Davis Polk advised Laekna, Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Regulation S. The net proceeds from the offering amounted to approximately HK$791 million. Founded in 2016, Laekna, Inc. is […]
Leave a Reply